Concepedia

Kimberly Maxfield

KM

Statistics

Publications

11

Citations

759

H-Index

11

Active since

2009

Affiliations

United States Food and Drug Administration(Current)

Pfizer (United States)

Bristol-Myers Squibb (United States)

Sanofi (United States)

Takeda (United States)

Kimberly Maxfield is an author at United States Food and Drug Administration specializing in medicine, biomedical sciences, and bioanalytical methodology.

Publications per year

2009–2024

11

Publications

11

Thin-Walled Microvessels in Human Coronary Atherosclerotic Plaques Show Incomplete Endothelial Junctions

Judith C. Sluimer, Frank D. Kolodgie, Ann Pascale Bijnens et al. · Journal of the American College of Cardiology · 2009 · 361 citations · Full text

, , +8

Comprehensive functional characterization of cancer–testis antigens defines obligate participation in multiple hallmarks of cancer

Kimberly Maxfield, Patrick Taus, Kathleen Corcoran et al. · Nature Communications · 2015 · 125 citations · Full text

, , +16

Multiple Cancer Testis Antigens Function To Support Tumor Cell Mitotic Fidelity

Kathryn M. Cappell, Rebecca Sinnott, Patrick Taus et al. · Molecular and Cellular Biology · 2012 · 75 citations · Full text

, , +17

FDA Approval Summary: Mobocertinib for Metastatic Non–Small Cell Lung Cancer with <i>EGFR</i> Exon 20 Insertion Mutations

Elizabeth S. Duke, Liza Stapleford, Nicole Drezner et al. · Clinical Cancer Research · 2022 · 40 citations · Full text

, , +15

2021 White Paper on Recent Issues in Bioanalysis: TAb/NAb, Viral Vector CDx, Shedding Assays; CRISPR/Cas9 &amp; CAR-T Immunogenicity; PCR &amp; Vaccine Assay Performance; ADA Assay Comparability &amp; Cut Point Appropriateness ( <u>Part 3</u> – Recommendations on Gene Therapy, Cell Therapy, Vaccine Assays; Immunogenicity of Biotherapeutics and Novel Modalities; Integrated Summary of Immunogenicity Harmonization)

LiNa Loo, Shannon Harris, Mark Milton et al. · Bioanalysis · 2022 · 36 citations · Full text

, , +16

1–5 of 11